Results 161 to 170 of about 24,681 (243)

Reliable Apparent Permeability Prediction Through Benchmarking, Stability, Uncertainty Quantification, and Explainable Machine Learning

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 8, August 2026.
ABSTRACT Apparent permeability (Papp$$ {P}_{app} $$) of a drug molecule serves as a principal indicator of drug absorption for pharmacokinetic modeling, and accurate prediction of Papp$$ {P}_{app} $$ values using machine learning would avoid time‐consuming and expensive In Vitro experiments.
Rajdeep Mondal   +3 more
wiley   +1 more source

Machine Learning Enables Rapid Prediction of Acid‐Reducing Agent Drug Interactions: A Streamlined Complement to PBPK Modeling

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 8, August 2026.
Machine Learning Enables Rapid Prediction of Acid‐Reducing Agent Drug Interactions: A Streamlined Complement to PBPK Modeling. ABSTRACT pH‐dependent drug–drug interactions (DDIs) commonly occur when acid‐reducing agents (ARAs) are co‐administered with weakly basic drugs.
Yuanfang Qin   +6 more
wiley   +1 more source

A Systematic Review of Published Physiologically Based Pharmacokinetic Models for Drug Excretion Into Human Breastmilk: Knowledge Gaps and Opportunities to Optimize Reporting and Modeling Practices

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 8, August 2026.
ABSTRACT Physiologically based pharmacokinetic (PBPK) modeling is increasingly used to predict infant exposure to medications via breast milk. Existing guidance on reporting of PBPK modeling analyses is unstructured and nonbinding to researchers. We evaluated reporting practices and modeling approaches in published PBPK modeling studies.
Joshua Kiptoo   +8 more
wiley   +1 more source

Discovery of Spirochromanone‐Based Molecular Hybrids as Promising Anticancer Leads: An Integrated Experimental and Theoretical Study

open access: yesChemistrySelect, Volume 11, Issue 31, 17 August 2026.
This work shows the new class of spirochromanone‐based molecular hybrids as promising anticancer agents. Several compounds displayed promising activity against RAMOS cells with an IC50 range of 1.11–1.47 µM, and CCRF‐CEM cells with an IC50 range of 7.71–13.55 µM.
Ramesh Reddy Mudda   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy